statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cellectis S.A. (NASDAQ:CLLS - Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.74 and traded as high as $2.75. Cellectis...

Cellectis (NASDAQ:CLLS) Shares Pass Above Fifty Day Moving Average of $2.74

NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS NASDAQ: CLLS) (the Company ), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

Cellectis announces the drawdown of the second tranche of  15 million under the credit facility agreement entered with the European Investment Bank (EIB)

This indicator may be signaling that CLLS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Cellectis SA (CLLS, $3.09) entered Downtrend as Momentum indicator drops below 0 level on Jan 02, 2024

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Cellectis - ADR

Cellectis

Volume	14,710.00
52-Wk High	$3.77
52-Wk Low	$0.9628

CLLS Cellectis

About

Feed

News

Sentiment

Earnings

Fundamentals